GlassScriptPhysician profile
Jae K Kim
NPI 1083642839
$2,169.45
in general payments reported to CMS, 2019-2025
12 companies · $239 in 2025
The $239 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $275 · 2020: $12.14 · 2021: $52.98 · 2022: $59.88 · 2023: $298 · 2024: $1,233 · 2025: $239.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $777 · Food and Beverage: $593 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $400.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $776.68 |
| Food and Beverage | $592.90 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $400.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $652.16 | 2024 | |
| Abbvie INC. | $400.00 | 2024 | |
| Pfizer INC. | $383.74 | 2019-2025 | |
| Kestra Medical Technology Services, INC. | $223.13 | 2024-2025 | Assure Wcd |
| Actelion Pharmaceuticals US, INC. | $141.92 | 2019 | |
| Organogenesis INC. | $124.52 | 2023 | Puraply |
| Janssen Pharmaceuticals, INC | $72.42 | 2019-2024 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $68.47 | 2021-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $36.17 | 2024 | Lifevest |
| Allergan, INC. | $27.67 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $20.15 | 2019 | |
| Novo Nordisk INC | $19.10 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jae Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.